LPATH
Lpath, Inc. is the category leader in the discovery and development of monoclonal antibodies that target (neutralize) bioactive lipids. The study of lipids (called lipidomics) is an emerging field of research that has already identified dozens of bioactive lipids that contribute to disease, with the promise of hundreds more as funding in the area continues to accelerate. Once a disease-causing lipid is identified, however, the challenge becomes one of generating a compound that neutralizes the relevant bioactive lipid. With its ImmuneY2:tm: platform technology and robust patent estate, Lpath is uniquely positioned to meet such challenges and exploit these opportunities.
LPATH
Industry:
Biopharma Biotechnology Medical Device
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.lpath.com
Total Employee:
11+
Status:
Active
Contact:
858-678-0800
Email Addresses:
[email protected]
Total Funding:
29.91 M USD
Technology used in webpage:
LiteSpeed CPanel Smart App Banner Google No Translate Namecheap DNS Namecheap Hosting Google Plus Embedded Posts
Similar Organizations
Capella BioScience
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Founder
Stock Details
Official Site Inspections
http://www.lpath.com
- Host name: ec2-18-119-154-66.us-east-2.compute.amazonaws.com
- IP address: 18.119.154.66
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
